Azerbaijan vs Gambia: The number of people with susceptibility test result for rifampicin
Azerbaijan
1,409
in 2021
Gambia
1,175
in 2021
Azerbaijan rank
59th
Gambia rank
62nd
The number of people with susceptibility test result for rifampicin over time
- Azerbaijan
- Gambia
How they compare
Azerbaijan currently reports 1,409 against 1,175 in Gambia, a difference of 234.
That makes Azerbaijan's figure about 1.2 times Gambia's.
Across all 5 years both countries report, Azerbaijan has been ahead every year.
Azerbaijan ranks 59th and Gambia ranks 62nd of 155 countries.
Azerbaijan has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Azerbaijan | Gambia | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 1,956 | 1 | 1,955 | Azerbaijan |
| 2020s | 1,327 | 646 | 681 | Azerbaijan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Azerbaijan or Gambia?
- Azerbaijan, at 1,409 against 1,175 in Gambia as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Azerbaijan and Gambia?
- 234, with Azerbaijan ahead.
- How many years of comparable data are there for Azerbaijan and Gambia?
- 5 years are reported by both, from 2017 to 2021.
- How do Azerbaijan and Gambia rank globally for the number of people with susceptibility test result for rifampicin?
- Azerbaijan ranks 59th and Gambia ranks 62nd of 155 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid refreshes it automatically from the source and publishes the full history for both places.